ESTIMATION OF OVARIAN RESERVE IN FEMALES WITH UNREALIZED FERTILITY WITH ENDOMETRIOMAS
Keywords:
ovarian functioning, ovarian reserve, endometrioid ovarian cysts, hormonal treatment, dienogestAbstract
We have observed 71 female patients aged from 19 to 45 with endometrioid ovarian cysts (EOC) up to 3 cm. Functional ovarian state has been evaluated (antral follicle count, folliculogenesis in both affected and collateral ovaries, intraovarian blood flow). Effectiveness of hormonal treatment has been assessed in case of small endometrioid cysts (up to 3 cm) in females of reproductive age. Anti-Mullerian Hormone (AMH) level was measured before and after the treatment.
References
Лапина И.А., Озолиня Л.А., Патрушев Л.И., Насырова Н.И., Авагян С.В. Особенности системы гемостаза у пациенток с эндометриоидными кистами яичников // Гинекология. 2015. № 3. С. 9-12.
Леваков С.А., Хамошина М.Б. Эндометриоз: мировой прорыв в медикаментозном лечении // Status Praesents, 2012.
Прилепская В.Н., Иванова Е.В., Тагиева А.В., Летуновская А.Б. Эндометриоз: от трудностей диагностики к новым возможностям терапии. Гинекология. 2012. № 4. С. 4-8.
Ширинг А.В. Клинико-патогенетические особенности формирования эндометриоза яичников у пациенток репродуктивного возраста: автореф. дис. … канд. мед. наук: 14.01.01. – Ростов н/Д, 2012. 23 с.
Щукина Н.А., Буянова С.Н. Современный взгляд на диагностику и лечение эндометриоза // РМЖ. 2014. №14. С. 1002.
Kitajima M. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endomeyriomas // Fertil. Steril. 2014. Vol. 101. № 4. P. 1031-1103.
Kohler G., Faustmann T.A., Gerlinger C. A dose - randing study to determine the efficacy and safety of 1,2, and 4 mg of dienogest daily for endometriosis // Int. J. Gyn. Obst. 2010. Vol. 108. P. 21–25.
Somigliana E. The presens of ovarian endometriomas is associated with a reduced responsiveness to gonadotropins // Fertil. Steril. 2012. Vol. 86. P. 192-196.
Strowitzki T., Marr J. Gerlinger C. Dienogest is effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week randomized, multicenter, open — label trial // Hum. Reprod. 2010. Vol. 25. № 3. P. 633–641.
Tilly J.L., Pru J.K., Rueda B.R. Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves caspase-8 and is defective in caspase-3 deficient mice // The Ovary. 2011. Ch. 19. P. 321-345. (in Russian)
Vercellini P. Endometriosis: current and future medical therapies // Best. Pract. Res. Clin. Obst. Gyn. 2014. Vol. 22. № 2. P. 275–306.
Zhang X. Redox-induced apoptosis of human oocytes in resting follicles in vitro // J. Soc. Gynecol. Investig. 2012. Vol. 13. P. 451– 458.
